Thank you for joining us
today. Industry Innovations Webinars are archived on the ATS YouTube channel
under the Industry Innovation playlist. https://www.youtube.com/playlist?list=PLFyO68a-Ji3n0xo20dmiQGvtDk9e2dKeH
Expect a brief satisfaction survey via email. Your feedback is appreciated as it helps improve programming for the future.
A Path to Asthma Control:
DUPIXENT® (dupilumab) Is the Only Biologic Indicated for OCS-Dependent Asthma.
This program is sponsored by Regeneron Sanofi Genzyme.
By registering for this webinar, you agree your information will be shared with the sponsor.
No CME or MOC credits are available for this program.
Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.